Q

Quotient Sciences | Nottingham

Research site

(Unclaimed)

Location

Mere Way Ruddington Fields, Nottingham, Nottingham, England

Site insights

Top conditions

Top treatments

anle138b

BMS-986165

BOS172767

Relugolix

FDL169

NM-101

DNDI-0690

GLPG3970

Trimethoprim

14C-NW-3509

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 60 total trials

A Study to Assess the Effect of Famotidine on the Drug Levels of Afimetoran in Healthy Participants

The purpose of this study is to confirm there is no significant effect of gastric pH changes of famotidine on the drug levels of afimetoran in health...

Enrolling

Healthy Volunteers

Drug: Afimetoran

Drug: Famotidine

A Two-Part First-In-Human Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GUB014295

This is a two-part, single centre, double-blind (within cohorts), randomised, placebo-controlled, single (Part 1) and multiple (Part 2) ascending sub...

Enrolling

Overweight

Healthy Volunteers

Drug: GUB014295-PLACEBO

Drug: GUB014295

Single and Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of NM-101

This is a Phase I, double-blind, randomised, two-part, single-ascending dose (Part 1) and multiple-ascending dose (Part 2) study of NM-101 in healthy...

Not yet enrolling

Parkinson Disease

Drug: NM-101

Drug: Placebo

Study to Evaluate Drug Levels of Various Solid Gastro-retentive Formulations of Deucravacitinib (BMS-986165) in Healthy Participants

The purpose of this study is to identify drug levels of gastro-retentive (GR) formulations which prolong retaining time in the stomach of deucravacit...

Enrolling

Healthy Participants

Drug: Deucravacitinib